NuScale Power SMR Stock Jumps As Nuclear AI Deal Fuels Momentum

NuScale Power (SMR +5.07%) has a market cap near $4B, driven by a potential deal with TVA for 72 of its 77-MW reactors. However, NuScale is not a party to the agreement, which was signed between TVA and ENTRA1 Energy, its commercialization partner. NuScale would supply the reactor technology but not own or operate the plants. The deal is non-binding, and NuScale has paid $507.4M in milestone payments to ENTRA1, with larger payments pending. NuScale's Q2 2026 revenue was $75K, and it has no net i

NuScale Power (SMR), a small modular reactor company, has seen its stock fall 83% from its peak, with short sellers profiting from its decline. The company has little revenue but $1.9B in cash, and analysts have mixed views on its prospects. U.S. data-center power demand is projected to grow, but fuel shortages and delayed reactor timelines pose challenges.

NuScale Power has overcome significant regulatory challenges, positioning itself to benefit from the growing demand for nuclear power driven by AI data centers. The company's opportunities with TVA and ENTRA1 could serve as a commercial validation for investors, with UAMPS providing insights into project economics. A successful deployment may bolster NuScale's long-term growth prospects.

NuScale Power (NYSE: SMR), the only U.S. company approved to build small modular reactors (SMRs), is awaiting a power purchase agreement (PPA) with the Tennessee Valley Authority (TVA). Bank of America analysts see nuclear energy as a $10 trillion opportunity, with SMRs potentially reshaping the industry. NuScale's stock price reflects market skepticism due to past project cancellations, but a PPA could significantly boost its value.

NuScale Power (NYSE:SMR) reported Q2 2026 revenue of $75,000, down 99.1% YoY, and announced a $750M share offering, causing a 6% drop in its stock. The company has $1.9B in cash but faces revenue volatility and delayed commercial deployment. Peers like Fluor (NYSE:FLR) and BWX Technologies (NYSE:BWXT) show divergent performance.

NuScale (SMR) reported a 99% revenue drop to $75,000 in Q2, but cash reserves grew $900M to $1.9B due to stock offerings. Revenue is lumpy, relying on FEED studies and licensing. Deployment of SMRs is expected in the early 2030s. The company plans further stock sales, raising dilution concerns.